Tonix Pharmaceuticals Holding Corp. (TNXP) stock
TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.82−0.12 (-4.08%)
Close on Nov 18, 2026Market cap $48.37MP/E –Yield –
Tonix Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Tonix Pharmaceuticals's market cap was $64.99M on Nov 11, 2026, against $162.39M a year earlier. Over the last 5 years it ranged from $1.43M to $29.34B, with a median of $203.19M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $64.99M | -59.1% |
| 2025 | Dec 31, 2025 | $158.83M | +209.4% |
| 2024 | Dec 31, 2024 | $51.33M | -77.6% |
| 2023 | Dec 29, 2023 | $229.06M | -94.5% |
| 2022 | Dec 30, 2022 | $4.16B | -85.8% |
| 2021 | Dec 31, 2021 | $29.34B | +52.6% |
| 2020 | Dec 31, 2020 | $19.22B | +5034.0% |
| 2019 | Dec 31, 2019 | $374.40M | -92.0% |
| 2018 | Dec 31, 2018 | $4.69B | -91.2% |
| 2017 | Dec 29, 2017 | $53.21B | +90.2% |
| 2016 | Dec 30, 2016 | $27.98B | -90.5% |
| 2015 | Dec 31, 2015 | $294.53B | +131.8% |
| 2014 | Dec 31, 2014 | $127.08B | +28.4% |
| 2013 | Dec 31, 2013 | $98.98B | +181.2% |
| 2012 | Dec 31, 2012 | $35.20B | – |
See a number that looks wrong?